ライフサイエンスコーパス: calcium phosphate

1 its chemical difference from bone mineral (a calcium phosphate).

2 adjuvants (aluminum hydroxide (Al(OH)(3)) or calcium phosphate).

3 erved as endogenous eumelanin and authigenic calcium phosphate.

4 eve a pH of 9, and filtration of principally calcium phosphate.

5 eve a pH of 9, and filtration of principally calcium phosphate.

6 es abrogated their ability to nucleate basic calcium phosphate.

7 with or without the addition of 200 mg Ca as calcium phosphate.

8 suspending media to permit precipitation of calcium phosphate.

9 nthophores, iridophores, and melanophores-in calcium phosphate.

10 of autunite and adsorption (43 +/- 4%) onto calcium phosphate.

11 nium uptake on the pathway for reaction with calcium phosphates.

12 ruvite (56-60 U(Slope)), calcium oxalate and calcium phosphate (17-59 U(Slope)), and brushite (4-15 U

13 rathyroid hormone, and serum levels of total calcium, phosphate, 25-hydroxyvitamin D, 1,25-dihydroxyv

14 iochemical parameters of mineral metabolism (calcium, phosphate, 25-hydroxyvitamin D, and parathyroid

15 e composition was determined in 11 patients: calcium phosphate (55%), calcium oxalate (18%), mixed ca

16 mble, and its ability to stabilize amorphous calcium phosphate (ACP) - a capacity enhanced by ameloge

17 hetic nucleation complexes made of amorphous calcium phosphate (ACP) and Anx-A5 or of phosphatidylser

18 rmation in vitro by stabilizing an amorphous calcium phosphate (ACP) precursor phase.

19 meloblast distal membrane in which amorphous calcium phosphate (ACP) ribbons form and lengthen.

20 Particles of amorphous calcium phosphate (ACP) were incorporated into PE and PE

21 three principal constituents: (i) amorphous calcium phosphate (ACP), complexed in part with phosphat

22 enhances its capacity to stabilize amorphous calcium phosphate (ACP), the first mineral phase formed

23 tion with the initial formation of amorphous calcium phosphate (ACP).

24 laboratory data including serum creatinine, calcium, phosphate, alkaline phosphatase, and glomerular

25 BM) waste materials contain large amounts of calcium phosphate and are potentially useful sorbents fo

26 : calcium carbonate, calcium citrate malate, calcium phosphate and calcium bisglycinate.

27 ecent studies on: (1) the synthesis of novel calcium phosphate and calcium fluoride nanoparticles and

28 ted crystalline hydroxyapatite and amorphous calcium phosphate and carbonate, in conjunction with a h

29 is comprised of Mg(2+)-containing amorphous calcium phosphate and lipid-calcium-phosphate complexes

30 hosphate (55%), calcium oxalate (18%), mixed calcium phosphate and oxalate (9%), and struvite (18%).

31 sein micelles, and modifying their colloidal calcium phosphate and the ratio of soluble to micellar c

32 ticle systems, such as gold, silver, silica, calcium phosphates and various polymers.

33 iagenetic impregnation and encrustation with calcium phosphate, and differences in X-ray attenuation

34 n lower supersaturation for calcium oxalate, calcium phosphate, and uric acid.

35 involve abnormalities in sodium, potassium, calcium, phosphate, and magnesium.

36 FGF-23, PTH, 25(OH)D3, calcitriol, calcium, phosphate, and urinary fractional excretion of

37 glycosuria, resulting in possible effects on calcium, phosphate, and vitamin D homeostasis.

38 Serum calcium, phosphate, and vitamin D levels were normal.

39 These rats uniformly form calcium phosphate (apatite) kidney stones and have been

40 and shrimps) shifted toward the formation of calcium phosphate as the main mineral at specified locat

41 to alumina-based, hydroxyapatite-based, and calcium phosphate-based bioceramics was demonstrated.

42 abolically active and perpetually remodeling calcium phosphate-based endoskeleton in terrestrial vert

43 Calcium phosphate-based materials have been widely used

44 Calcium phosphate-based mineralo-organic particles form

45 tment with a combination of EMD and biphasic calcium phosphate (BC) or EMD alone.

46 Basic calcium phosphate (BCP) crystal deposition underlies the

47 ium pyrophosphate dihydrate (CPPD) and basic calcium phosphate (BCP) crystals are common components o

48 Basic calcium phosphate (BCP) crystals are common components o

49 Although basic calcium phosphate (BCP) crystals are common in osteoarth

50 Basic calcium phosphate (BCP) deposition results from depresse

51 ta-tricalcium phosphate (beta-TCP), biphasic calcium phosphate (BCP), and bovine bone mineral on vert

52 ta-tricalcium phosphate (beta-TCP), biphasic calcium phosphate (BCP), bovine bone mineral (BBM) or bl

53 s with other enamel matrix proteins and with calcium phosphate biominerals, and interaction with cell

54 Calcium phosphate bions (CPB) are biomimetic mineralo-or

55 We identified calcium phosphate both within osteoblast mitochondrial g

56 etal-free chiral phosphoric acids and chiral calcium phosphates both catalyze highly enantio- and dia

57 ic acid, cystine, struvite, calcium oxalate, calcium phosphate, brushite), and 20 were of polycrystal

58 by folding, and by supporting deposition of calcium phosphate by osteoblasts cultured in these scaff

59 biopolymers) to cover crystal and amorphous calcium phosphate [Ca (x)(PO(4)) (y)], forming CaP granu

60 Two control groups were also prepared-calcium phosphate (CaCl2.2H2O + K2HPO4 in buffer solutio

61 on of amorphous calcium carbonate, amorphous calcium phosphate, calcite and apatite at various skelet

62 haracteristics of pre-nucleation clusters of calcium phosphate, calcium carbonate, iron(oxy)(hydr)oxi

63 Polycrystalline calcium oxalate and calcium phosphate calculi were found throughout the enti

64 biologics have been used in combination with calcium phosphate (CaP) ceramics, however, they have rec

65 tion of titanium (Ti) microtopography with a calcium phosphate (CaP) coating with and without peptide

66 ed multi-shell nanoparticles consisting of a calcium phosphate (CaP) core coated with siRNA directed

67 Calcium phosphate (CaP) dental resins with Ca and P ion

68 Uremic pruritus with elevated levels of calcium phosphate (CaP) in skin is a common symptom in p

69 widespread in biomedical applications, where calcium phosphate (CaP) mineral coatings are used to imp

70 Calcium phosphate (CaP) minerals may comprise the main p

71 with decreased stability and dissolution of calcium phosphate (CaP) minerals.

72 Biomaterials containing calcium phosphate (CaP) moieties have been shown to supp

73 Calcium phosphate (CaP) nanoparticles (NP) with an asymm

74 ovel vaccination approach with biodegradable calcium phosphate (CaP) NPs that serve as carrier of imm

75 e matrix and the release of free Ca(2+) from calcium phosphate (CaP) precipitates.

76 e exposed to a PPi-stabilized supersaturated calcium phosphate (CaP) solution containing 0 to 0.06 mg

77 ine (MCT), monophosphoryl lipid A (MPLA) and calcium phosphate (CaP) used less frequently.

78 ed freeze-dried bone allograft (DFDBA), or a calcium phosphate (CaP), were coated with either EMD liq

79 allows for investigation of the formation of calcium phosphate (CaP)-based minerals by (31)P NMR-a pr

80 hemical system for P removal and recovery as calcium phosphate (CaP).

81 is unknown whether such effect can stimulate calcium phosphate (CaP)/calcium oxalate (CaOx) stone for

82 s are composed of calcium oxalate (CaOx) and calcium phosphate (CaP); 10% of struvite (magnesium ammo

83 (8DSS) peptides to promote the nucleation of calcium phosphate carbonate from free ions.

84 d the uniform deposition of nano-crystalline calcium phosphate carbonate over demineralized enamel su

85 le collagen sponge composite (TCP/HA/ACS) or calcium phosphate cement (alpha-BSM).

86 udy was to encapsulate hBMSCs and hUCMSCs in calcium phosphate cement (CPC) scaffolds for dental, cra

87 ot segments that were capped on one end with calcium phosphate cement, and the entire system was impl

88 ivo remineralization capacity of resin-based calcium-phosphate cement (Ca-P) used for indirect pulp-c

89 ivo remineralization capacity of resin-based calcium-phosphate cement (Ca-PO(4)) used for indirect pu

90 Calcium phosphate cements (CPCs) have excellent biocompa

91 affinity, supplementing the role of protein-calcium-phosphate chelates.

92 ndings in salivary physiology, biochemistry, calcium phosphate chemistry related to saliva, microbiol

93 of conditions characterized by deposition of calcium phosphate complexes in soft connective tissues.

94 aining amorphous calcium phosphate and lipid-calcium-phosphate complexes (CPLXs) and the lipid-depend

95 is driven by homogeneous nucleation at high calcium phosphate concentration and the only macromolecu

96 tion deficit with an increased prevalence of calcium phosphate-containing kidney stones.

97 p27b1 null mice on either a normal or a high calcium/phosphate-containing rescue diet were treated wi

98 Compared with calcium phosphate control, a contraction of the unit cel

99 ube induced microstructural phase changes of calcium phosphate (CP) leading to the formation of brush

100 of calcium pyrophosphate dihydrate and basic calcium phosphate crystal arthritis are reviewed.

101 in calcium pyrophosphate dihydrate and basic calcium phosphate crystal deposition diseases.

102 ular calcification most likely by preventing calcium phosphate crystal growth and inducing cellular m

103 ing search for effective therapies for basic calcium phosphate crystal-associated diseases.

104 vement of protein kinase C isoforms in basic calcium phosphate crystal-mediated matrix metalloprotein

105 he lumps were due to subsurface formation of calcium phosphate crystalline deposits.

106 2 during hemodialysis for 52 weeks inhibited calcium phosphate crystallization (placebo: 15%; 300 mg:

107 ) during hemodialysis for 12 weeks inhibited calcium phosphate crystallization by nearly 70%.

108 w a direct correlation between inhibition of calcium phosphate crystallization in plasma and inhibiti

109 SNF472, a calcification inhibitor, on plasma calcium phosphate crystallization using spectrometric me

110 SNF472 dose-dependently inhibited calcium phosphate crystallization, which correlated with

111 In addition, basic calcium phosphate crystals activate the transcription fa

112 Calcium pyrophosphate dihydrate and basic calcium phosphate crystals are common components of oste

113 of calcified deposits and suggest that small calcium phosphate crystals could destabilize atheroscler

114 Basic calcium phosphate crystals have also been found to upreg

115 Basic calcium phosphate crystals have been shown to increase p

116 Basic calcium phosphate crystals have long been associated wit

117 nsible for the exquisite organization of the calcium phosphate crystals in enamel.

118 Vascular calcification, the formation of calcium phosphate crystals in the vessel wall, is mediat

119 Studies in macrophages have suggested that calcium phosphate crystals induce the release of proinfl

120 In the present study, we found that calcium phosphate crystals induced cell death in human a

121 Calcium phosphate crystals of approximately 1 microm or

122 tudies have been performed on the effects of calcium phosphate crystals on vascular smooth muscle cel

123 ings have emphasized the potential for basic calcium phosphate crystals to stimulate the production o

124 alkaline phosphatase levels and accumulated calcium phosphate crystals.

125 e, calcium pyrophosphate dihydrate and basic calcium phosphate crystals.

126 dicate that the lateral packing of nanoscale calcium-phosphate crystals in collagen fibrils can be re

127 ures composed of paper supporting regions of calcium phosphate deposited by osteoblasts.

128 anium surface roughened with nanometer-scale calcium phosphate deposition (nanoscale calcium phosphat

129 ls with CaOx crystal deposition, or inducing calcium phosphate deposition by increasing dietary phosp

130 in calcium pyrophosphate dihydrate and basic calcium phosphate deposition diseases identifies a subse

131 ing that PS may provide nucleating sites for calcium phosphate deposition on the vesicles.

132 a genetic disease characterized by cerebral calcium-phosphate deposition and associated with neurops

133 n autosomal recessive trait characterized by calcium phosphate deposits in myocardial tissue.

134 ) is a neurological disease characterized by calcium phosphate deposits in the basal ganglia and othe

135 diffuse tubular injury with abundant tubular calcium phosphate deposits on renal biopsy are referred

136 Calcium phosphate did not alter the leaching profile, al

137 phonic acid biomimetic analogs for amorphous calcium phosphate dimension regulation and collagen targ

138 ichiometry, we quantify a possible impact of calcium phosphate dissolution on the maintenance of F0F1

139 mouse liver and transfected with PEI DNA and calcium phosphate DNA nanoparticles in 384-well plates.

140 Runx2 deletion did not affect serum calcium, phosphate, fibroblast growth factor-23, or alka

141 avage product (P148) can inhibit spontaneous calcium phosphate formation in vitro by stabilizing an a

142 hosphorylated and non-phosphorylated LRAP on calcium phosphate formation.

143 sess the effect of amelogenin proteolysis on calcium phosphate formation.

144 s specialized structures in which a layer of calcium phosphate, frequently in the form of crystalline

145 Recovery of calcium phosphate granules (CaP granules) from high-stre

146 Our findings suggest that calcium phosphate granules form physical barriers that i

147 inducerons, including Ca(2+) and PO(4) (3-) Calcium phosphate graphene (CaPG) intrinsically induces

148 tion, avoidance of infection, and control of calcium-phosphate homeostasis also is essential.

149 iated through the effects of 1,25(OH)(2)D on calcium-phosphate homeostasis and inflammation.

150 dividuals with CKD, a population with unique calcium-phosphate homeostasis, is unknown.

151 In addition to its classical role in calcium-phosphate homeostasis, vitamin D has anti-inflam

152 PTHrP) are two related peptides that control calcium/phosphate homeostasis and bone development, resp

153 was synthesised by mixing PCL with layers of calcium phosphate (hydroxyapatite, brushite and monetite

154 Nanocrystals of apatitic calcium phosphate impart the organic-inorganic nanocompo

155 cale calcium phosphate deposition (nanoscale calcium phosphate-impregnated titanium [NCPIT]).

156 er was used to examine the role of amorphous calcium phosphate in CPLX nucleational activity, which w

157 important relationship between intracellular calcium phosphate in osteoblasts and their role in miner

158 ion after grafting with a synthetic biphasic calcium phosphate in sinuses with minimal bone height, t

159 d from 23 patients confirmed a prevalence of calcium phosphate in the form of hydroxyapatite.

160 Au-HDL, iodine-based contrast material, and calcium phosphate in the phantoms.

161 try (SIMS) imaging confirmed the presence of calcium phosphate in the spherules and identified choles

162 f four common adjuvants: aluminum hydroxide, calcium phosphate, incomplete Freund's adjuvant, and the

163 IL-6/p-BTK/p-ERK signaling mediates calcium phosphate-induced pruritus.

164 ensional bioceramic implants comprising of a calcium phosphate inner core, with moderate in vitro deg

165 iated controlled transformation of amorphous calcium phosphate into crystalline HAP was confirmed by

166 ion is used to capture inorganic phosphate, calcium phosphate is converted to lead phosphate, and su

167 omposed of chitosan-amelogenin (CS-AMEL) and calcium phosphate is effective in forming an enamel-like

168 In contrast, spherical amorphous calcium phosphate is formed in the presence of OSC.

169 In these structures, calcium phosphate is not merely co-precipitated with the

170 ly developed a potent mannose-modified lipid calcium phosphate (LCP) nanoparticle (NP)-based Trp2 vac

171 nuclide (177)Lu based on the versatile lipid-calcium-phosphate (LCP) nanoparticle delivery platform.

172 Lipid-calcium-phosphate (LCP) nanoparticles represent a new cl

173 The Lipid/Calcium/Phosphate (LCP) nanoparticles (NPs) with a membr

174 We found that when calcium phosphate levels, not matrix free calcium, reach

175 osits, and demonstrate the presence of basic calcium phosphate-like whitlockite crystals in intervert

176 d, but octacalcium phosphate-like, amorphous calcium phosphate-like, and HPO4(2-)-enriched phases wer

177 rt with phosphatidylserine (PS) to form (ii) calcium-phosphate-lipid complexes (CPLX), and (iii) anne

178 Electroporation and calcium phosphate-mediated procedures were used to deliv

179 er liposome-mediated transfection than after calcium-phosphate-mediated transfection.

180 ydroxyvitamin D3 [1,25(OH)2D3] formation and calcium-phosphate metabolism.

181 n addition to its well-characterized role in calcium/phosphate metabolism, has been found to have reg

182 ergranular phase of Mg-substituted amorphous calcium phosphate (Mg-ACP).

183 This study investigated if calcium phosphate microspheres, which have remineralizin

184 ation of VSMCs and was independent of a high calcium-phosphate milieu.

185 del for a citrate bridging between layers of calcium phosphate mineral a double salt octacalcium phos

186 TRIP-1 promoted the nucleation and growth of calcium phosphate mineral aggregates.

187 ions between collagen fibrils and amelogenin-calcium phosphate mineral complexes lead to oriented dep

188 into its role as a nucleator of crystalline calcium phosphate mineral formation.

189 Tetracyclines stain calcium phosphate mineral in bone.

190 te interactions with both forming and mature calcium phosphate mineral phases, providing new insights

191 anisms of its assembly and interactions with calcium phosphate mineral, we conducted FTIR spectroscop

192 function, and the importance of controlling calcium phosphate mineralization at the nanometer scale.

193 have implications for amelogenin-controlled calcium phosphate mineralization in vitro and may offer

194 lexible membrane suggested to be involved in calcium phosphate mineralization of the club, as indicat

195 on leading to an inappropriate deposition of calcium phosphate minerals in advanced atherosclerotic p

196 The in situ or authigenic formation of calcium phosphate minerals in marine sediments is a majo

197 tes play a critical role in the formation of calcium phosphate minerals in marine sediments.

198 ain the puzzlingly dispersed distribution of calcium phosphate minerals observed in marine sediments

199 ith (17)O NMR data for OCP-citrate and other calcium phosphate minerals relevant to bone.

200 Correlation of the calcium:phosphate molar ratio with release of phosphate

201 effect of incorporation of micro-silica and calcium phosphate monobasic to radiopacified TCS-based m

202 posite containing nanoparticles of amorphous calcium phosphate (NACP) and quaternary ammonium dimetha

203 posite containing nanoparticles of amorphous calcium phosphate (NACP).

204 ndblasted, large-grit, acid-etched (SLA); 2) calcium phosphate nano-coated (CaP); 3) anodized; or 4)

205 erratia sp. bacterium manufactures amorphous calcium phosphate nanominerals (BHAP); this material has

206 n and temporarily stabilize the newly formed calcium phosphate nanoparticle precursors by sequesterin

207 ion of antimicrobial, protein-repellent, and calcium phosphate nanoparticle remineralization was sugg

208 2O2) using rhodamine isocyanide incorporated calcium phosphate nanoparticles (Rho/CaP) was developed.

209 lts explain a role for constitutively formed calcium phosphate nanoparticles in the gut lumen and sho

210 formation of amorphous magnesium-substituted calcium phosphate nanoparticles that trap soluble macrom

211 tilize aminoethyl anisamide-conjugated lipid-calcium-phosphate nanoparticles to deliver plasmid DNA e

212 the crystals formed in ATD5 cells were basic calcium phosphate, not calcium pyrophosphate dihydrate,

213 y studies further confirmed that the nascent calcium phosphate nuclei formed in solution were assembl

214 nanoparticles of either calcium carbonate or calcium phosphate on an isolated piece of pig skin (in v

215 Biomaterials made of calcium phosphate or bioactive glasses are currently ava

216 and the ultimate deposition of either basic calcium phosphate or calcium pyrophosphate dihydrate cry

217 There were no significant changes in serum calcium, phosphate, or intact parathyroid hormone during

218 blast cell cultures, 1,25(OH)(2)D(3) but not calcium, phosphate, or parathyroid hormone stimulated FG

219 ral bone disorder (MBD) parameters including calcium, phosphate, parathyroid hormone (PTH), fibroblas

220 31) we also measured plasma levels of FGF23, calcium, phosphate, parathyroid hormone, and vitamin D m

221 ene delivery in fibroblasts using nano-sized calcium phosphate particles (NCaPP) as vectors.

222 The calcium phosphate particles can be used as building bloc

223 ardiovascular disease and detected spherical calcium phosphate particles, regardless of the presence

224 of 3D scaffolds using magnetic levitation of calcium phosphate particles.

225 lants with and without added nanometer-sized calcium phosphate particles.

226 linium salts, which allows the levitation of calcium phosphate particles.

227 s, the initially formed metastable amorphous calcium phosphate phase transformed into thermodynamical

228 y shows the presence of an acidic disordered calcium phosphate phase with additional characteristic f

229 carbonate- and silicate-substitutions in the calcium phosphate plaques found in myringosclerosis.

230 They control nucleation of calcium phosphate polymorphs and the assembly of hierarc

231 ated that GRP-78 can induce the formation of calcium phosphate polymorphs by itself, when bound to im

232 e the encapsulation of Trp2 peptide into the calcium phosphate precipitate core of LCP, two phosphor-

233 xogenously introduced calcium in the form of calcium phosphate precipitates (CPP) induces autophagy.

234 d the main surface P species to be amorphous calcium phosphate precipitates, phosphate groups in poly

235 ate group on serine 16, was found to inhibit calcium phosphate precipitation and stabilize ACP format

236 tion of CaCO(3) particles, which facilitates calcium phosphate precipitation by buffering the formed

237 entin mineralization and prevent spontaneous calcium phosphate precipitation in areas in which minera

238 less than 2 h of hands-on time; however, the calcium phosphate precipitation method contains several

239 In comparison to calcium phosphate precipitation or the phosphomolybdate-

240 xperimental conditions supported spontaneous calcium phosphate precipitation with the initial formati

241 ed methods to transform Dictyostelium cells: calcium phosphate precipitation, resulting in high copy

242 lower enamel decalcification with extensive calcium-phosphate precipitation.

243 hat facilitate the formation of an amorphous calcium phosphate precursor which gradually transforms i

244 omimetic hydroxyapatite through an amorphous calcium phosphate precursor.

245 se of biomimetic analog-stabilized amorphous calcium phosphate precursors.

246 the effect of platelet-rich fibrin/biphasic calcium phosphate (PRF/BCP) on differentiation and survi

247 > or =3.5 g/dl), hemoglobin (> or =11 g/dl), calcium-phosphate product (<60 mg(2)/dl(2)), dose (Kt/V

248 rtality, whereas traditional risk factors or calcium-phosphate product did not.

249 ted with higher BPV included obesity, higher calcium-phosphate product levels, and lower hemoglobin c

250 more potently than phosphate (at equivalent calcium-phosphate product).

251 raditional (Framingham) risk factors and the calcium-phosphate product.

252 a passive process resulting from an elevated calcium-phosphate product.

253 d serum levels of creatinine, phosphate, and calcium-phosphate product; dietary fructose significantl

254 No cases reported elevated calcium-phosphate products (0 of 17 [0%]).

255 Dental cements containing calcium phosphate promote remineralization.

256 Importantly, dietary normalization of calcium, phosphate, PTH, and FGF23 rescued the skeletal

257 at bran, oat bran and white bean had a lower calcium:phosphate ratio than barley bran and red kidney

258 lectron microscopy that 100-300 nm amorphous calcium phosphate regions are present in the disordered

259 a mixture of ferrihydrite and amorphous iron-calcium phosphate replaces the more soluble Mg-ACP, rend

260 alysis can induce an artefactual, nanoscale, calcium phosphate-rich, amorphous coating on nanoparticl

261 defects in sheep using 3D-printed customized calcium phosphate scaffolds with or without surgical vas

262 As calcium phosphate seems to be the preferred initial soli

263 onsequently, the probes were encapsulated in calcium phosphate/silicate nanoparticles (diameter ca. 2

264 eating cells, and consist of polycrystalline calcium phosphate similar to the mineral found in bones

265 ction in supersaturation with respect to the calcium phosphate solid phase may be the mechanism by wh

266 y incorporated into a newly formed amorphous calcium phosphate solid.

267 s added to a suspension containing amorphous calcium phosphate solids as well as dissolved calcium an

268 At pH 7.5, a condition at which calcium phosphate solids could form, the uptake mechanis

269 r uranium contacted with preformed amorphous calcium phosphate solids.

270 first 2 s after preparation of oversaturated calcium phosphate solutions, PNS with a hydrodynamic rad

271 r, concomitant wound care, and management of calcium-phosphate status.

272 or combined with chlorthalidone in reducing calcium phosphate stone formation and improving bone qua

273 In summary, sodium thiosulfate reduces calcium phosphate stone formation in the genetic hyperca

274 and potassium citrate combined would reduce calcium phosphate stone formation more than either medic

275 netic hypercalciuric rat, an animal model of calcium phosphate stone formation, we studied the effect

276 n, which may not be beneficial in preventing calcium phosphate stone formation.

277 th groups had similar numbers of exclusively calcium phosphate stones.

278 In this model, all animals form calcium phosphate stones.

279 allow quantitative assessment of individual calcium phosphates such as hydroxyapatite (HAP) from mix

280 tassium citrate on urine calcium oxalate and calcium phosphate supersaturation and stone formation is

281 no statistically significant differences in calcium phosphate supersaturation or upper limit of meta

282 Furthermore, calcium oxalate and calcium phosphate supersaturation were higher with potas

283 lone or with chlorthalidone, increased urine calcium phosphate supersaturation, but chlorthalidone di

284 levels lead to increased calcium oxalate and calcium phosphate supersaturation.

285 reatment lowered urine pH, which would lower calcium phosphate supersaturation.

286 te-treated rats, changes that would increase calcium phosphate supersaturation.

287 p.E161K carriers were more likely to contain calcium phosphate than stones of wild-type patients.

288 Clay minerals inter-finger with calcium phosphate that co-precipitated with the clays in

289 des of observations describing intracellular calcium phosphate, the precise role osteoblasts play in

290 d to mediate the transformation of amorphous calcium phosphate to apatite crystals under the same exp

291 s their ability to sequester nanoclusters of calcium phosphate to form a core-shell structure, in a f

292 LB/c mice were anesthetized and treated with calcium phosphate to induce AAA and underwent weekly PET

293 inetic investigation of the precipitation of calcium phosphate using a process widely found in microo

294 Au-HDL, an iodine-based contrast agent, and calcium phosphate were imaged in a variety of phantoms.

295 The contrast agents and calcium phosphate were imaged in phantoms.

296 applications of nanoparticulate polymers and calcium phosphates will also be assessed.

297 he precipitates were predominantly amorphous calcium phosphate with a phosphorus content of 11.1-13.3

298 We designed an in vitro experiment with calcium phosphate with different SDF concentrations (0.3

299 In this study, nucleators based on amorphous calcium phosphate (with or without Anx-5) were prepared

300 ur objective was to test the hypothesis that calcium phosphate would better support anabolic bone bui